Cancers, Free Full-Text

Por um escritor misterioso
Last updated 01 julho 2024
Cancers, Free Full-Text
As lung cancer has the highest cancer-specific mortality rates worldwide, there is an urgent need for new therapeutic and diagnostic approaches to detect early-stage tumors and to monitor their response to the therapy. In addition to the well-established tissue biopsy analysis, liquid-biopsy-based assays may evolve as an important diagnostic tool. The analysis of circulating tumor DNA (ctDNA) is the most established method, followed by other methods such as the analysis of circulating tumor cells (CTCs), microRNAs (miRNAs), and extracellular vesicles (EVs). Both PCR- and NGS-based assays are used for the mutational assessment of lung cancer, including the most frequent driver mutations. However, ctDNA analysis might also play a role in monitoring the efficacy of immunotherapy and its recent accomplishments in the landscape of state-of-the-art lung cancer therapy. Despite the promising aspects of liquid-biopsy-based assays, there are some limitations regarding their sensitivity (risk of false-negative results) and specificity (interpretation of false-positive results). Hence, further studies are needed to evaluate the usefulness of liquid biopsies for lung cancer. Liquid-biopsy-based assays might be integrated into the diagnostic guidelines for lung cancer as a tool to complement conventional tissue sampling.
Cancers, Free Full-Text
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Cancers, Free Full-Text
Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. - Abstract - Europe PMC
Cancers, Free Full-Text
Game Rong Den 5 Get File - Colaboratory
Cancers, Free Full-Text
from Flow Cytometry to Cytomics, Page 2
Cancers, Free Full-Text
Cancer Free Posters for Sale
Cancers, Free Full-Text
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial - The Lancet
Cancers, Free Full-Text
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
Cancers, Free Full-Text
Epigenetic regulation during cancer transitions across 11 tumour types
Cancers, Free Full-Text
Cancers, Free Full-Text

© 2014-2024 importacioneskab.com. All rights reserved.